ʻO ka papa lāʻau lapaʻau 209216-23-9 Entecavir Monohydrate no ka mālama ʻana i ka maʻi Hepatitis B.
Huahanainoa | Entecavir monohydrate |
Nā huaʻōlelo like | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate |
CAS No. | 209216-23-9 |
Ka nana aku | ʻO ka pauka keʻokeʻo keʻokeʻo |
ʻĀpana Molekala | C12H15N5O3.H2O |
Kaumaha Molekala | 295.30 |
Hoʻohana | Lapaʻau Lapaʻau a i ʻole ke kumu noiʻi |
Hoʻopili | E like me kāu noi |
Waihona | E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu |
Entecavir monohydrate Cas: 209216-23-9 | ||
Nā mea | Kūlana | Nā hualoaʻa |
Ka nana aku | ʻO ka pauka keʻokeʻo keʻokeʻo | Hoʻokō |
ʻO ka hoʻololi ʻana | +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) | +27.0° |
ʻIkepili | A: Na IR, E hoʻohālikelike me ka hana maʻamau | Hoʻokō |
B: Ma ka HPLC, pono e hoʻopaʻa i ka manawa me ka hana maʻamau | Hoʻokō | |
Wai | 5.8%—6.5% | 6.1% |
Isomer | Hoʻokahi ≤0.1% | 0.02% |
Huina ≤0.5% | 0.02% | |
Na mea pili | Hoʻokahi haumia ≤0.1% | 0.05% |
Huina haumia ≤0.3% | 0.07% | |
Ke koena ma ka ʻā | ≤0.1% | 0.04% |
Nā metala kaumaha | £ 10ppm | Hoʻokō |
Nā mea hoʻoheheʻe koena | Pono e kūlike me ka maʻamau | Hoʻokō |
Hoʻāʻo | ≥99.8% | 99.9% |
Ka hopena:Hoʻokō i nā kūlana i loko o ka hale. |
ʻIkepili Hui
√ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai; √ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi; √ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai; √ Keʻena hana R&D kūʻokoʻa; √ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia; √ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau; √ Kiʻekiʻe Efficiency hui hana me ke ala mau.E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou